Clinical trials
Rectal Neoplasms trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 9 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maria Sklodowska-Curie National Research Institute of Oncology | 6 |
| Jagiellonian University | 4 |
| Amgen | 2 |
| Pfizer | 2 |
| Polish Colorectal Cancer Study Group | 2 |
| ADVANCED MARKER DISCOVERY S.L. | 1 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Adlai Nortye Biopharma Co., Ltd. | 1 |
| Esperas Pharma Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 30 |
| Colonic Neoplasms | 13 |
| Colorectal Neoplasms | 11 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
| Breast Neoplasms | 2 |
| Digestive System Diseases | 2 |
| Endometrial Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
| Intestinal Neoplasms | 2 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.